A growing number of states are taking action to ensure broad access to COVID-19 vaccines as respiratory virus season approaches.

The state-level moves come after the FDA limited approval of updated shots to individuals 65 and older, and those with at least one condition that puts them at high risk for severe disease. The narrow approvals drew criticism from healthcare groups, which have said the decision will cause confusion and create new access hurdles, which could limit uptake and further strain the nation’s healthcare system in the coming months.

The Advisory Committee on Immunization Practices, which provides vaccine recommendations to the CDC, met Sept. 18-19 to discuss and vote on vaccines for COVID-19, hepatitis B, and measles, mumps, rubella and varicella. For COVID-19 vaccin

See Full Page